Page 5 - Biotechnology Vector News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Some 12.1 mln have received their first vaccine dose, Deputy Prime Minister Tatyana Golikova said MOSCOW, April 27. /TASS/. More than 12 mln Russians have received at least one dose of a coronavirus vaccine, and 7.7 mln have been fully vaccinated, Deputy Prime Minister Tatyana Golikova said at a meeting of the Council of Legislators of the Russian Federation on Tuesday. "As many as 12.1 mln of our fellow citizens have received their first vaccine dose and 7.7 mln have been fully vaccinated," she revealed. Read also Golikova specified that 28 mln double vaccine doses had been produced in Russi...

8 Apr in 13:00 Just one day will be enough to update Russia's EpiVacCorona vaccine to ensure protection against new mutations of the coronavirus, the Russian State Research Center of Virology and Biotechnology Vector's General Director Rinat Maksyutov said. "If the virus suddenly mutates, and a mutation occurs in the areas where we selected peptides, if we need to update the vaccine, then it will take no more than one day to upgrade vaccine composition," Maksyutov said. Vector's director clarified that developing peptides and releasing a vaccine takes time, apart from that, research must...

Providing enough doses of the vaccine for Russians remains a priority, according to the researcher Read also MOSCOW, April 7. /TASS/. Russia’s center Vector has received many requests already for the anti-coronavirus vaccine EpiVacCorona from abroad and such messages keep pouring in, but providing enough doses of the vaccine for Russians remains a priority, the chief of Vector’s Yekaterinburg Research Institute of Viral Infections, Alexander Semyonov, said on the Vesti FM radio station on Wednesday. "There have been many requests but our priority is to produce enough vaccines for the citi...

EpiVacCorona was a second vaccine to have been certified in Russia MOSCOW, April 7. /TASS/. The vaccine EpiVacCorona will be able to protect the vaccinated at least for one year, the chief of the Yekaterinburg Research Institute of Viral Infections (an affiliate of the center Vector), Alexander Semyonov, said on Wednesday. Read also "One year, certainly. Theoretically, its effects should last two years. For the time being we are cautious about official forecasts, because too little time has passed. The first vaccinated patients received the shots just recently," Semyonov said on the Vesti FM ...

7 Apr in 15:40 Russia’s vaccine EpiVacCorona is effective against the British and South African mutations of the novel coronavirus, the chief of the Yekaterinburg Research Institute of Viral Infections Vector, Alexander Semyonov said on the Vesti FM radio station. "This vaccine [EpiVacCorona] works against all strains that exist, that are known at the moment, including the British, South American and South African ones," he said. Semyonov said should new coronavirus strains emerge, it would be possible to promptly modify the vaccines accordingly. "In this respect EpiVacCorona, just like Sp...